8th Congress of the European Society of Minimally Invasive Neurological Therapy

8th Congress 2016

September 8-10, 2016 Acropolis Convention Centre - Nice, France “Doubt can only be removed by action“

 th Joint meeting with EANS 4 on Sept. 8, 2016 Stroke session with ESO on Sept. 9, 2016

Final Program www.esmint.eu

Organized by

Committees President of the 8th ESMINT Congress Jens FIEHLER, Germany

Vice-President of the 8th ESMINT Congress

Thursday September 8, 2016 First symposium for angiosuite personnel 08:30 First symposium for nurses, 13:00 technicians and radiographers p.4

Patrick A. BROUWER, Sweden

ESMINT Congress Scientific Committee: Urs FISCHER, Switzerland Andreas GRÜBER, Austria Antonin KRAJINA, Czech Republic Zsolt KULCSÀR, Switzerland Laurent PIEROT, France Phil WHITE, United Kingdom

ESMINT Executive Board: President: Istvan SZIKORA, Hungary General Secretary: Laurent PIEROT, France Treasurer: Patrick A. BROUWER, Sweden

Gallieni room, level 2

Thursday September 8, 2016 Joint meeting with EANS Vascular Section 08:30

Keynote lectures: Complications after SAH p.5

10:00 Coffee break 10:30

Debates session: Aneurysm therapy

12:00

Delegate cases: Aneurysm (part 1) p.6

p.5

Editorial

12:30 Industry sponsored symposium p.19

Dear ESMINT friends,

13:00 Lunch buffet

We are happy to welcome you to the 8th ESMINT Congress in Nice. 

14:00 Industry sponsored symposium p.19

After the historical breakthrough with the positive thrombectomy trials last year, we need to get back to business. This must not mean to business as usual. We are encountering substantial developments representing both significant challenges and great opportunities that we are going to address during the Congress. First, numbers of neurointerventions have increased enormously. Educating and training young Neurointerventionalists is a fundamental challenge while keeping up with the increasing workload. Second, the importance of Neurointerventionalists as members of the interdisciplinary neuro-team has further increased. ESMINT needs to describe standardized processes, write guidelines and implement quality controls. Third, interventional technology is advancing with ever-increasing speed. We need to make sure that modifications in technology are translated into real clinical benefit for our patients. We wish you a very enjoyable and educational congress.

Jens Fiehler, President of the 8th Congress Patrick A. Brouwer, Vice-President of the 8th Congress

14:30

Keynote lectures: Challenges in management

p.6

15:30 Industry sponsored symposium p.19 16:00 Tea break

16:30

Keynote lectures: Training

p.6

17:15

Delegate cases: ESMINT’s got talent p.7

18:00

Delegate cases: Aneurysm (part 2)

p.7

18:30 ESMINT General Assembly

p.7

PROGRAM AT A GLANCE Friday September 9, 2016

Saturday September 10, 2016

Morning session with ESO 08:00

Keynote lectures: Stroke interventions p.8

09:30

Delegate cases: Stroke (part 1) p.8

10:00 Coffee break

Debates session:

08:00

Debates session: New devices p.11

09:30

New technology symposium 

09:45

New technology symposium  p.21

p.21

10:00 Coffee break

10:30 Thrombectomy debates -

Acute stroke p.9 10:30

Keynote lectures: Recent studies p.11

12:30 Industry sponsored symposium p.19

11:30

New technology symposium  p.21

13:00 Lunch buffet

11:45

New technology symposium  p.21

14:00 Industry sponsored symposium p.19

12:00

New technology symposium  p.21

14:30 Honorary membership

p.9

12:15

New technology symposium  p.21

14:55 EJMINT best paper award

p.9

12:30 Lunch buffet

p.9

13:30

12:00 Industry sponsored symposium p.19

15:10

ESMINT Diploma Examination Award Ceremony

15:20 Best European studies

16:05

p.9

Keynote lecture: Ethical concerns: who should run and analyse INR studies p.9

Keynote lectures: Imaging of intervention p.12

14:30 Delegate cases  p.12 16:10 Closing remarks

16:30 Tea break 17:00 Invited cases: my worst case 

p.10

17:45 Delegate complication cases

p.10

20:00 Social cocktail dinner

p.10

8th Congress 2016

p.12

Thursday September 8, 2016 First Symposium for angiosuite personnel 08:30-13:00 First symposium for nurses, technicians and radiographers Gallieni room, level 2 Moderators: J. DOSHE, Sweden - H. GENINS, Sweden - K. JONES, Australia A. MASTENBROEK, Netherlands - F. MENU, France 08:30 Opening 08:50 General anesthesia vs. Sedation L. PIEROT, France

09:10 Stroke Transport S. GUIGO, France

09:30 How we decreased patient turn-over time / telestroke N. SOLENSKI, USA

10:00 Coffee break in the exhibition hall (level 3) 10:30 Physiology/Pathology of clots P.A. BROUWER, Sweden

10:50 Why is imaging so important? M. BENDSZUS, Germany

11:10 Non interventional treatment options N. SOLENSKI, USA

11:30 Different stentrievers I. SZIKORA, Hungary

11:50 ADAPT technique G. GAL, Denmark

12:10 New devices

T. ANDERSSON, Sweden

12:30 C  omplications of IA treatment and how to solve them L. JENSEN, USA

12:50 Discussion

4

Thursday September 8, 2016 Joint Meeting with EANS Vascular Section 08:30-10:00 Complications after SAH Moderators: E. BOCCARDI, Italy - A. VAN DER ZWAN, Netherlands 08:30 Pathophysiology of delayed ischemia P. VAJKOCZY, Germany

08:48 Imaging predictors of delayed ischemia M. BENDSZUS, Germany

09:06 Pharmacotherapy for delayed ischemic deficit N. BAMBAKIDIS, USA

09:24 Endovascular therapy for delayed ischemic deficit A. BIONDI, France

09:42 Other secondary complications of SAH G. SCHUBERT, Germany

10:00-10:30 Coffee break in the exhibition hall 10:30-12:00 Debates session: Aneurysm therapy Moderators: H. HENKES, Germany - P. VAJKOCZY, Germany 0:30 Fusiform VB aneurysms - do we improve outcome? 1 Pro: C. TASCHNER, Germany - Con: D. LANGER, USA 10:50

Discussion

11:00 Wide neck aneurysm: prime time for endovascular therapy? Pro: L. PIEROT, France - Con: C. SCHIRMER, USA 11:20 Discussion 11:30 ICH removal before endovascular therapy? Pro: A. VAN DER ZWAN, Netherlands - Con: H. HENKES, Germany 11:50 Discussion

5

Thursday September 8, 2016 Joint Meeting with EANS Vascular Section 12:00-12:30 Delegate cases: Aneurysm (part 1) Moderator: L. PIEROT, France 12:00 WEB: Will 21 system allow enlargement of indications? L. PIEROT, France

12:10 The FRED PED Shred A. COON, USA

12:20 Fusiform dissecting aneurysm therapy: Challenging case P. DELGADO, Mexico

12:30-13:00 Industry sponsored symposium - see programme page 19 13:00-14:00 Lunch buffet in the exhibition hall 14:00-14:30 Industry sponsored symposium - see programme page 19 14:30-15:30 Challenges in management Moderators: N. BAMBAKIDIS, USA - M. SZAJNER, Poland 14:30 Non-aneurysmal SAH A. DEHDASHTI, USA

14:45 Complications of antiaggregation after endovascular therapy F. TURJMAN, France

15:00 SAH from fusiform and blister aneurysms A. GRUBER, Austria

15:15 Open Neurosurgery and Neurointervention in one OR D. FIORELLA, USA

15:30-16:00 Industry sponsored symposium - see programme page 19 16:00-16:30 Tea break in the exhibition hall 16:30-17:15 Training Moderators: A. GRUBER, Austria - D.K. LOPES, USA 16:30 Teaching surgery as an art or science? P. VAJKOCZY, Germany

16:45 How to teach open neurosurgical techniques? C. PRESTIGIACOMO, USA

17:00 How to teach endovascular techniques? T. ANDERSSON, Sweden

6

Thursday September 8, 2016 Joint Meeting with EANS Vascular Section 17:15-18:00 Delegate cases: ESMINT’s got talent Moderators: T. ANDERSSON, Sweden - J. FIEHLER, Germany - D.K. LOPES, USA M. SZAJNER, Poland 17:15 Severe stroke and severe SAH: who came first? A. PELLATON, Switzerland

17:30 A 3D printed model replicating a difficult aneurysm access A. FRÖLICH, Germany

17:45 Mechanical thrombectomy of a fenestrated basilar artery F. PULT, Switzerland

18:00-18:30 Delegate cases: Aneurysm (part 2) Moderator: F. TURJMAN, France 18:00 True hybrid management of a ruptured basal ganglia AVM Z. KULCSAR, Switzerland

18:10 Hybrid setting management of a giant MCA aneurysm Z. KULCSAR, Switzerland

18:20 Management of Giant and Large Cerebral aneurysms - When to stent? M. PUTHURAN, United Kingdom

18:30-19:30 ESMINT General Assembly

7

Friday September 9, 2016 Morning session with ESO 08:00-09:30 Stroke interventions Moderators: A. KRAJINA, Czech Republic - K. LEES, United Kingdom 08:00 Thrombectomy taskforce: do we have enough interventionalists? U. FISCHER, Switzerland

08:13 Training Guidelines for Endovascular Ischemic Stroke Intervention I. SZIKORA, Hungary

08:26 Influence of the multisociety training document on US practice M.V. JAYARAMAN, USA

08:39 Individual Patient Data Meta-Analysis of Randomized Trials C. MAJOIE, Netherlands

08:52 Basilar occlusion F. TURJMAN, France

09:05 Thrombectomy in Sinus thrombosis J. COUTINHO, Netherlands

09:15 Update intracranial stenting R. CHAPOT, Germany

09:30-10:00 Delegate cases: Stroke (part 1) Moderators: M. SÖDERMAN, Sweden - R. STANCIULESCU, Romania 09:30 Thrombectomy af an asymptomatic stroke patient D. BRISBOIS, Belgium

09:40 Minimizing door-to-groin time with flat-detector CT (FDCT) M. PSYCHOGIOS, Germany

09:50 An “original” case of intracranial stenosis P. MACHI, Switzerland

10:00-10:30 Coffee break in the exhibition hall 10:30-12:00 Debates session: Thrombectomy debates - Acute stroke Moderators: U. FISCHER, Switzerland - J. GRALLA, Switzerland 10:30 IV tPA in proximal occlusions Pro: M. MAZIGHI, France - Con: U. FISCHER, Switzerland 10:50 Discussion 11:00 Acute stenting in tandem occlusions Pro: V. COSTALAT, France - Con: G. THOMALLA, Germany 11:20 Discussion 11:30 Narrow selection criteria for thrombectomy Pro: K. LEES, United Kingdom - Con: J. GRALLA, Switzerland 11:50 Discussion 8

Friday September 9, 2016 12:00-12:30 Industry sponsored symposium - see programme page 19 12:30-13:00 Industry sponsored symposium - see programme page 19 13:00-14:00 Lunch buffet in the exhibition hall 14:00-14:30 Industry sponsored symposium - see programme page 19 14:30-14:55 Honorary membership Introducer: I. SZIKORA, Hungary Honorary member: K.G. TER BRUGGE, Canada 14:55-15:10 EJMINT best paper award Introducer: L. PIEROT, France Award winner: W.H. VAN ZWAM, Belgium 15:10-15:20 ESMINT Diploma Examination - Award Ceremony Moderators: T. ANDERSSON, Sweden - J. BYRNE, United Kingdom S. RENOWDEN, United Kingdom 15:20-16:05 Best European studies Moderators: J. FIEHLER, Germany - C. TASCHNER 15:20 First results from the Giant Intracranial Aneurysm Registry – a prospective, interdisciplinary, international observational study J. DENGLER, Germany 15:35  TOPSAT 2- Trial of Poor Grade Subarachnoid Haemorrhage Treatment 2 P. WHITE, United Kingdom 15:50 A Trial Comparing Transfer to the Closest Local Stroke Center vs. Direct Transfer to Endovascular Stroke Center of Acute Stroke Patients with Suspected Large Vessel Occlusion in the Catalan Territory (RACECAT) M. RIBO, Spain 16:05-16:30 Keynote lecture: ethical concerns 16:05 Ethical concerns: who should run and analyse INR studies P.A. BROUWER, Sweden

16:30-17:00 Tea break in the exhibition hall

9

Friday September 9, 2016 17:00-17:45 Invited cases: my worst case Moderators: H. HENKES, Germany - Z. KULCSAR, Switzerland 17:00  H. HENKES, Germany 17:15  D.K. LOPES, USA 17:30 N. KOCER, Turkey 17:45-18:25 Delegate complication cases Moderators: H. HENKES, Germany - Z. KULCSAR, Switzerland 17:45 Novel balloon application for rescue and realignment of a proximalend migrated pipeline flex embolization device into the aneurysmal sac: complication management M. GALDAMEZ, Spain

17:55 Microcatheter rupture during on Onyx injection causing ICA/MCA occlusion treated with mechanical thrombectomy V. GUPTA, USA

18:05 Intra-operative rupture, coil entrapment and carotid dissection: All-In Z. KULCSAR, Switzerland

18:15 Trans-anterior communicating artery angioplasty of a proximal-end unopened Pipeline Embolization Device M. GALDAMEZ, Spain

20:00-23:00 Social cocktail dinner

10

Castel plage, 8 quai des Etats-Unis, Nice 19:45 - Bus departure in front of Novotel, NH and Aston Hotels

Saturday September 10, 2016 08:00-09:30 Debates session: New devices Moderator: C. TASCHNER, Germany 8:00 Enrol the first patient into an RCT 0 Pro: J. RAYMOND, Canada - Con: J. MORET, France 08:20

Discussion

08:30 Intraneurysmal flow disruptors - ready for prime time? Pro: S. CEKIRGE, Turkey - Con: C. COGNARD, France 08:50 Discussion 09:00 Imaging as primary trial endpoint Pro: P. WHITE, United Kingdom - Con: C. STAPF, Canada 09:20 Discussion 09:30-10:00 New technology Industry symposium - see programme page 21 09:30 New technology symposium 09:45 New technology symposium 10:00-10:30 Coffee break in the exhibition hall 10:30-11:30 Recent studies Moderators: L. RENIERI, Canada - P. WHITE, United Kingdom 10:30 THRACE: follow-up and lessons learned S. BRACARD, France

10:50 THERAPY: follow-up and lessons learned J.D. MOCCO, USA

11:10 ARUBA: follow-up and lessons learned C. STAPF, Canada

11:30-12:30 New technology Industry symposium - see programme page 21 11:30 11:45 12:00 12:15

New technology symposium New technology symposium New technology symposium New technology symposium

12:30-13:30 Lunch buffet in the exhibition hall

11

Saturday September 10, 2016 13:30-14:30 Imaging of intervention Moderators: A. DORFLER, Germany - L. SPELLE, France 13:30 Imaging based intervention planning L. SPELLE, France

13:55 Advanced intraprocedural imaging J.H. BUHK, Germany

14:10 Imaging follow up of intervention - when and how? A. DORFLER, Germany

14:30-16:10 Delegate cases Moderators: J. RAYMOND, Canada - A. VAN ES, Netherlands 14:30 Parenchymal AV-fistula with mesencephalic bleeding: a pre-existing or post-hemorrhagic entity? Z. KULCSAR, Switzerland

14:40 Is there a source of bleeding? MRI will help A. PELLATON, Switzerland

14:50 A "suspended" case C. MICHELOZZI, France

15:00 Difficult case of MCA aneurysm with branches arising from the dome combination of advanced endovascular techniques M. MIS, Poland

15:10 Alternative detachment technique for electrically detachable coils Y. KIM, Republic of Korea

15:20 Case of not expanded proximal part of P64 FLOW DIVERTER stent and dealing with it M. MIS, Poland

15:30 Combination of WEB and Fred Jr for aneurysm treatment: Is it useful? L. PIEROT, France

15:40 Direct aspiration first pass technique vs. stent-retriever supported mechanical thrombectomy in acute basilar artery occlusion. A retrospective single center experience. A. ABRAMYUK, Germany

15:50 dual WEB treatment in acute SAH M. BESTER, Germany

16:00 Wide Neck MCA Aneurysm Embolization with pCONus Remodeling: Prospective Deployment and Sizing Test in Patient Specific FLOWMODDA 3D Printed Aneurysm model A. KEMMLING, Germany

16:10-16:25 Closing remarks 12

E-POSTERS Visit the e-posters area located in the exhibition hall! You will be able to consult all the cases selected by the Scientific Committee on the computers displayed in this area. 1- Aneurysm therapy EP-01

Middle Cerebral Artery Aneurysms Treated with a Pipeline Flex Embolization Device RAUTIO Riitta, Turku University Hospital, FINLAND

EP-02

Endovascular treatment in subarachnoid hemorrhage with multiple cerebral aneurysms OZKUL Ayca, Adnan Menderes University Faculty of Medicine Neurology, TURKEY

EP-03

Failed ACom Clipping Treated with the WEB Device COON Alexander, Johns Hopkins University, USA

EP-04*

The FRED PED Shred COON Alexander, Johns Hopkins University, USA

EP-05

Neutralization of a twisted PED during giant aneurysm treatment: Advanced FDS salvage techniques using VIA 27 and Catalyst 5 catheters COLBY Geoffrey, Johns Hopkins University, USA

EP-06

Temporary stent assisted coil embolization of cerebral aneurysms YOON Wonki, The Catholic university of Korea, SOUTH KOREA

EP-07

Intra-procedural leak during endovascular coiling of unruptured intracranial aneurysms: a single-center experience CHO Su, Hee Asan medical center, SOUTH KOREA

EP-08*

Fusiform dissecting aneurysm therapy: challenging case DELGADO Primo, TEC Salud Monterrey, MEXICO

EP-09*

Difficult case of MCA aneurysm with branches arising from the dome - combination of advanced endovascular techniques MIS Marcin, University Hospital Wrocław, POLAND

EP-10*

Dual WEB treatment in acute SAH BESTER Maxim, University Hospital Hamburg Eppendorf, GERMANY

* Case presentation in the conference room

13

E-POSTERS EP-11*

Wide Neck MCA Aneurysm Embolization with pCONus Remodeling: Prospective Deployment and Sizing Test in Patient Specific FLOWMODDA 3D Printed Aneurysm model KEMMLING Andre, UKSH Luebeck, GERMANY

EP-12

Endovascular treatment of MCA aneurysms ZELENAK Kamil, Jessenius Faculty of Medicine and University Hospital, SLOVAKIA

EP-13

Fusiform PCA aneurysm tretated by FD implantation ZELENAK Kamil, Jessenius Faculty of Medicine and University Hospital, SLOVAKIA

EP-14*

Alternative detachment technique for electrically detachable coils KIM Youngsoo, Pusan national university Yangsan hospital, SOUTH KOREA

EP-15

Transradial approach for cerebral aneurysm treatment. A single centre inicial experience DOROSZUK Gustavo, El Cruce Hospital Florencio Varela, ARGENTINA

EP-16*

A 3D printed model replicating a difficult aneurysm access FRÖLICH Andreas, University Medical Center Hamburg-Eppendorf, GERMANY

EP-17*

Hybrid setting management of a giant MCA aneurysm KULCSAR Zsolt, Geneva University Hospitals, SWITZERLAND

EP-18*

WEB: Will 21 system allow enlargement of indications? PIEROT Laurent, CHU Reims, FRANCE

EP-19

Early Experience of Fred Jr. Flow Diverters RAUTIO Riitta, Turku University Hospital, FINLAND

EP-20

A Dissecting PCA Aneurysm: Endovascular Treatment with Telescopic Stenting UYSAL Ender, Sisli Hamidiye Etfal Training and Research Hospital, TURKEY

EP-21*

Combination of WEB and Fred Jr for aneurysm treatment: Is it useful? PIEROT Laurent, CHU Reims, FRANCE

EP-22*

Severe stroke and severe SAH: who came first? PELLATON Alain, University hospitals of Geneva, SWITZERLAND

EP-23*

Management of Giant and Large Cerebral aneurysms - When to stent? PUTHURAN Mani, The Walton Centre, UNITED KINGDOM

14

* Case presentation in the conference room

E-POSTERS 2- Acute ischemic stroke EP-24*

Direct aspiration first pass technique vs. stent-retriever supported mechanical thrombectomy in acute basilar artery occlusion. A retrospective single center experience. ABRAMYUK Andrij, Carl Gustav Carus University Hospital, GERMANY

EP-26

Thrombectomy in acute vertebrobasilar occlusion and vertebral V2 dissection in a 4 years-old child - difficulties to choose devices RUDNICKA Svetlana, Aarhus University Hospital, DENMARK

EP-27

Stroke treatment by the means of lesional aspiration and stent retrieval utilizing the novel Catalyst 6 aspiration catheter - a case example BEHME Daniel, Georg August University Göttingen, GERMANY

EP-28*

Thrombectomy af an asymptomatic stroke patient BRISBOIS Denis, CHC Liège, BELGIUM

EP-29

Two cases of intracranial stenting PITRONE Antonio, A.O.U. Policlinico G Martino, ITALY

EP-30*

Mechanical thrombectomy of a fenestrated basilar artery PULT Frauke, Neuroradiology, Bern University Hospital, SWITZERLAND

EP-31

Successful thrombectomy through the persistent trigeminal artery ROTHAUPT Jan, Klinikum Osnabrück, GERMANY

EP-32*

Minimizing door-to-groin time with flat-detector CT (FDCT) PSYCHOGIOS Marios, University Medicine Goettingen, GERMANY

EP-33

Animal trail results of A Novel Mechanical Thrombectomy Device AGID Ronit, Toronto Western Hospital, CANADA

3- Intra-and extracranial stenting EP-34

Difficult CAS (stenting at an origin of common carotid artery) KAWAI Masato, Rinku General Medical Center, JAPAN

EP-35

The way to rescue a failed stent-graft deployment YOON Changhyo, Kyungpook National University Hospital, SOUTH KOREA

* Case presentation in the conference room

15

E-POSTERS EP-36

Intracranial stent angioplasty - role after SAMMPRIS YOON Wonki, The Catholic university of Korea, SOUTH KOREA

EP-37 A role of fatty acid in carotid artery stenting

OHASHI Tomoo, Tokyo Medical University Ibaraki Medical Center, JAPAN

EP-38*

Case of not expanded proximal part of P64 FLOW DIVERTER stent and dealing with it MIS Marcin, University Hospital Wrocław, POLAND

EP-39* An “original” case of intracranial stenosis MACHI Paolo, HUG Geneve, SWITZERLAND

4- Complications EP-40*

Microcatheter rupture during on Onyx injection causing ICA/MCA occlusion treated with mechanical thrombectomy GUPTA Vikas, University of Missouri, USA

EP-41

Superior sagittal sinus IIb dural AVF treated with Onyx VUKASINOVIC Ivan, Clinical Center of Serbia, SERBIA

EP-43*

Intra-operative rupture, coil entrapment and carotid dissection: All-In KULCSAR Zsolt, Geneva University Hospitals, SWITZERLAND

EP-44

PED endoleak type I as complication MILOSEVIC MEDENICA Svetlana, Clinical Center of Serbia, SERBIA

EP-45

Mechanical thrombectomy of right M1 allowed for complete MCA recanalization and subsequent stent-assisted embolization of a ruptured, broad-based right Carotid-T aneurysm PANAGIOTOPOULOS Vasileios, University Hospital of Patras, GREECE

EP-46

Suspected Granulomatous Angiitis due to Foreign Body Embolization after Endovascular Neurointervention LEIDOLT Lars, Department of Diagnostic and Interventional Neuroradiology, University Hospital Bern, SWITZERLAND

16

* Case presentation in the conference room

E-POSTERS EP-47*

Novel balloon application for rescue and realignment of a proximal-end migrated pipeline flex embolization device into the aneurysmal sac: complication management M.GALDAMEZ Mario, Fundacion Jimenez Dia, SPAIN

EP-48*

Trans-anterior communicating artery angioplasty of a proximal-end unopened Pipeline Embolization Device M.GALDAMEZ Mario, Fundacion Jimenez Diaz, SPAIN

5- Imaging was the key EP-49*

A "suspended" case MICHELOZZI Caterina, Hopital PPR CHU Toulouse, FRANCE

EP-50*

Parenchymal AV-fistula with mesencephalic bleeding: a pre-existing or post-hemorrhagic entity? KULCSAR Zsolt, Geneva University Hospitals, SWITZERLAND

EP-51*

Is there a source of bleeding? MRI will help PELLATON Alain, University hospitals of Geneva, SWITZERLAND

6- Miscellaneous EP-52*

True hybrid management of a ruptured basal ganglia AVM KULCSAR Zsolt, Geneva University Hospitals, SWITZERLAND

EP-53

Spinal AVM embolization with liquid embolic Phil VUKASINOVIC Ivan, Clinical Center of Serbia, SERBIA

* Case presentation in the conference room

17

Smooth and stable. Target Detachable Coils deliver consistently smooth deployment and exceptional microcatheter stability. Designed to work seamlessly together for framing, filling and finishing. Target Coils deliver the high performance you demand. For more information, please visit www.strykerneurovascular.com/Target or contact your local Stryker Neurovascular sales representative.

Copyright © 2016 Stryker NV00018669.AA

18

SPONSORED SESSIONS INDUSTRY SYMPOSIUM



Thursday September 8 Recent Technologies in Aneurysm Treatment Moderator: M. PIOTIN, France

12:30 The Neuroform Atlas™ Stent System: Adapted to Distal Anatomy M. PIOTIN, France 13:00

Surpass™ Streamline™ Flow Diverter: Enhance Delivery with AXS Catalyst™ 5 Distal Access Catheter A. ARAT, Turkey

T herapy of Acute Aneurysms using the WEB Device: Field Reports and CLinical Evidence Moderator: C.COGNARD, France

14:00 Berlin Charité WEB Experience G. BOHNER, Germany 14:30

2 years of WEB in UKE Hamburg: a well-established therapy J.-H. BUHK, Germany Tilburg Experience with WEB in Ruptured Aneurysms J. PELUSO, Netherlands

Haemorrhagic and Acute Stroke Advanced Treatments Moderator: AC. JANUEL, France

15:30 Intermediate Results of ERASER (ERic Acute StrokE Recanalisation) J. FIEHLER, Germany 16:00 Preliminary results of SAFE (Safety and efficacy Analysis of FRED Embolic device in aneurysm treatment) L. PIEROT, France

Friday September 9 12:00 Solitaire™ Platinum : First clinical experience from the US 12:30 I. LINFANTE, USA  DAPT – Current developments in Direct Aspiration A First Pass Thrombectomy Thrombaspiration in posterior circulation stroke

12:30 J. GERBER, Germany 13:00

Clinical Experience with the Latest Stroke Thrombectony Technology:   ACE68 Perfusion Catheter J. FIFI, USA

Innovations in Neurointerventional Treatment: New Technologies from Codman Neurovascular Moderator: Z. KULCSÀR, Switzerland

14:00 Advances in Access systems - Introducing InNeuroCo. Catheters 14:30 E. PETERSON, USA PulseRider® as an Adjunctive Device for Endovascular Treatment of Aneurysms at a Bifurcation - Preliminary Experience from the UK T. PATANKAR, United Kingdom

19

20

SPONSORED SESSIONS 

NEW TECHNOLOGY NDUSTRY SYMPOSIUM Saturday September 10

Derivo: the new confidence level 09:30 Moderators: P.A. BROUWER, Sweden - J. FIEHLER, Germany - A. SCHUESSLER, Germany 09:45 S. PROTHMANN, Germany

Pflex Study: Preliminary Results 09:45 Moderators: P.A. BROUWER, Sweden - J. FIEHLER, Germany 10:00 M. MARTINEZ-GALDAMEZ, Spain

It All Starts with Access 11:30 Moderators: P.A. BROUWER, Sweden - J. FIEHLER, Germany 11:45 Initial Clinical Use of the New AXS Infinity long sheath A. ARTHUR, USA

New Era in thrombectomy devices 11:45 Moderators: P.A. BROUWER, Sweden - J. FIEHLER, Germany 12:00 H. HAKAN SELCUK, Turkey - B. KARA, Turkey

Embotrap II – Initial Clinical Experience 12:00 Moderators: P.A. BROUWER, Sweden - J. FIEHLER, Germany 12:15 C. TASCHNER, Germany

Copemic 2L: A new dual lumen balloon for safer coiling and stenting 12:15 in large arteries. Preliminary multicentric experience 12:30 Moderators: P.A. BROUWER, Sweden - J. FIEHLER, Germany P. MOSIMANN, Switzerland

SAVE THE DATE

9th Congress 2017

September 7-9, 2017 Nice, France

21

22

8th Congress 2016

Supported by: PLATINUM LEVEL

GOLD LEVEL

SILVER LEVEL

OTHER PARTNERS

BLOCKADE MEDICAL GALGO MEDICAL KANEKA PHARMA EUROPE MENTICE

MIVI NEUROSCIENCE PHENOX SIM & CURE SITS INTERNATIONAL

Organized by:

www.europa-organisation.com

23

GENERAL INFORMATION ACCREDITATION AND CERTIFICATE OF ATTENDANCE The 8th ESMINT Congress is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS), www.uems.net. The 8th ESMINT Congress is designated for a maximum of 18 hours of European external CME credits. Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity. Through an agreement between the European Union of Medical Specialists and the American Medical Association, physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 Credits™. Information on the process to convert EACCME credit to AMA credit can be found at www.ama-assn.org/go/internationalcme Download your certificate of attendance and CME credits after the congress from September 13th on www.esmint.com. The login and password are mentionned on your badge.

WIFI ACCESS Free Wifi access is provided in the exhibition area. Login: esmint2016 - Password: esmint2016

SOCIAL COCKTAIL DINNER ESMINT is pleased to invite you to the cocktail dinner on Friday, September 9. This invitation to the cocktail is not included in your registration fees. It is free of charge but the capacity is limited. Your attendance must be confirmed while collecting your badge, a dinner pass will then be given to you. Cocktail dinner from 20:00 to 23:00 at the Castel Plage, 8 quai des Etats-Unis, Nice Meeting point: in front of Novotel/NH and Aston Hotels, bus departure at 19:45

1

NICE CITY MAP

2

ESMINT Congress venue Acropolis Convention Centre

9th Congress 2017

9th Congress 2017

Hotels 1

Novotel

2

NH Hotel

3

Grand Hôtel Aston

4

Boscolo Exedra

5

Hôtel Beau Rivage

6

Méridien

4

3

5 6

24

Social cocktail dinner

EXHIBITION FLOOR PLAN TERRACE

14

B

12

A

7

15

6

H8

4

18

12

H5

E-posters

9

18sqm

H6

COFFEE BREAK AND LUNCHES

8

15

17

5

8

COFFEE BREAK AND LUNCHES

IS

14

16

16sqm

13

H7

11

Exhibitors list Acandis.................................... 08 Balt............................................ 17 Biba Medical........................... A Blockade Medical............... 16 Codman................................... 18 Esmint Society...................... 02 Galgo Medical...................... 07 Kaneka pharma................... 13 Neuravi.................................... 19 MicroVention........................ 03 MIVI Neuroscience............ 06 Medtronic............................... 11 Phenox..................................... 01 Penumbra............................... 12 Rapid Medical...................... 15 Sim & Cure............................. 14 SITS International............... 05 Stryker...................................... 04 WFITN Congress.................... B Hospitality suites Codman.................................. H6 Medtronic.............................. H2 Mentice.................................. H7 MicroVention....................... H4 Neuravi................................... H1 Penumbra.............................. H8 Phenox.................................... H3 Stryker..................................... H5

IS

19

1

3

2

H4

Hospital H1 Medtro H2 Penumb H3 Phenox H4 MicroVe H6 Codman H5 Stryker

H3

Exhibito Acandis ...... Asahi Intec Balt Extrus Biba Medic Blockade M Codman N Esmint Soc Medtronic . MicroVenti Neuravi ...... Penumbra . Phenox ....... Sequent M SITS Intern Stryker Neu

CONFERENCE ROOM H2

H1

Private Office

Preview Room

Meeting Room

Welcome Desk Cloackroom

25

WEB™ Intrasaccular Flow Disruptor Revolutionizing Aneurysm Treatment

MicroVention Welcomes All Attendees to the 8th ESMINT Congress

MicroVention Industry Symposium R

Therapy of Acute Aneurysms using the WEB™ Device: Field Reports and CLinical Evidence

LB0134 A

Thursday, September 8, 2016 - 14:00 to 14:30

R

The WEB Aneurysm Embolization System and VIA Microcatheter have both received the CE Mark. The WEB is not approved or available for sale in the US. MICROVENTION is a registered trademark of MicroVention, Inc.

26

microvention.com

You are cordially invited to a MicroVention Sponsored Symposium Thursday, September 8th • 15:30 – 16:00 PM Main Conference Room

Hemorrhagic and Acute Stroke Advanced Treatments Intermediate Results of ERASER ERic Acute StrokE Recanalisation Prof. Jens Fiehler, Director of the Department of Diagnostic and Interventional Neuroradiology at the University Medical Center Hamburg-Eppendorf in Germany

Preliminary Results of SAFE Safety and Efficacy Analysis of FRED Embolic Device in Aneurysm Treatment Prof. Laurent Pierot, Professor of Radiology, Faculty of Medicine, Reims Head of the Department of Radiology, University Hospital, Reims in France

Moderator: Dr. Anne-Christine Januel, Senior Interventional Neuroradiologist at University Hospital in Toulouse, France INDICATIONS FOR USE The FRED® System is intended for endovascular embolization of intracranial neurovascular aneurysms. The FRED® System may also be used with embolic coils for the treatment of intracranial neurovascular lesions. The ERIC® Retrieval Device is intended for use in the revascularization of acute ischemic stroke caused by the intracranial occlusive vessels of patients who are not eligible for intravenous tissue plasminogen activator, IV tPA, or who fail IV tPA therapy. MICROVENTION, FRED and ERIC are registered trademarks of MicroVention, Inc. Refer to Instructions for Use, contraindications and warnings for additional information. © 2016 MicroVention, Inc.

27

BETTER BY DESIGN. BACKED BY DATA.

0

%

Symptomatic Intracerebral Haemorrhage sICH 1

60

%

Positive Clinical Outcomes (mRS 0-2) 1

100

%

SolitaireTM Device Utilization in SWIFT PRIME 1

Solitaire Revascularization Device TM

Esmint, Nice. 8th-10th September, 2016 Visit us at booth #11 Les mentions obligatoires sont disponibles sur demande. REFERENCES: 1 Saver JL, Goyal M, Bonafe A, et al. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N. Engl. J. Med. Jun 11 2015;372(24):2285-2295. Indications, contraindications, warnings and instructions for use can be found in the product labeling supplied with each device. CAUTION: Federal (U.S.A.) law restricts this device to sale by or on the order of a physician.

www.medtronic.eu UC201703194 EE © 2016 Medtronic. All rights reserved.